Investigators initiated trials are very essential of any research to be translated from bed to bedside. The inception of these research are done with a scientific interest in a new or existing drug or device, to generate new ideas, and mostly involve collaborative research between different departments and also different types of researchers.
It becomes essential to understand the significance of investigator-initiated trials and different ways to ensure human subject protection.
Let our expert presenter Dr. Nagina Parmar help you win over investigator-initiated trials by helping you identify the investigator deficiencies. With the help of PowerPoint presentation and references, learn how to ensure protection of human subjects in clinical trials and much more.
Here’s just a sample of what you’ll learn:
Who should attend? Principle Investigators, Senior Clinical Research Associates (CRAs), Clinical Research Project Manager, Contract Research Organizations (CROs), Institutional Review Boards (IRBs), Site Management Organizations (SMOs)
- Casper E. Uldriks
Dr. Nagina Parmar is a certified clinical research professional and senior clinical research Associate at the Hospital for Sick Children in Toronto. Dr. Parmar is also involved in teaching Biology, Microbiology, Life Sciences for Clinical practice, Principles of clinical research undergraduate and graduate courses at Ryerson University. She has published more than 30 journal articles and reviews in various national and international journals. Currently, she coordinating various Phase I, II...
More Events By The Speaker